Our Research & Development
Dr Emmanuel CANET
Executive Vice-President Research & Development
“Our ambition is to answer, quickly and efficiently, the needs of our patients in areas where they have major needs.”
Servier organizes its R&D in 5 large therapeutic areas where it has extensive know-how and recognized expertise and in which there are important unmet needs of patients: cardiovascular, immune and inflammatory, and neuropsychiatric diseases, as well as cancer and diabetes. Servier draws on the excellence of its 2800 R&D employees worldwide, 600 of whom are in France, to develop effective treatment solutions.